Condition: Urologic Chronic Pelvic Pain Syndrome (UCPPS) · Interstitial Cystitis · Bladder Pain Syndrome · Sponsor: State University of New York at Buffalo
The EPPIC (Easing Pelvic Pain Interventions Clinical Research Program) study evaluates an ultra-brief, 4 session cognitive behavioral pain treatment transdiagnostic in design for urologic chronic pain syndrome (UCPPS) with clinical and practical advantages over existing behavioral therapies whose length and focus limits their adoption by clinicians and coverage for mechanistically similar comorbidities. A theoretically informed, practical, empirically grounded approach will systematically unpack CBT's working mechanisms, clarify for whom it works, ease dissemination, appeal to patients, providers, payers, and policy makers in the COVID-19 era favoring low resource intensity treatments, and reduce cost and inefficiencies associated with high intensity therapies whose complexity, length, and scarcity restricts uptake and impact.
This description comes directly from the study's public registry record.
Jeffrey Lackner, PsyD · 716-898-5671 · lackner@buffalo.edu
Patricia O'Leary, EdM · 716-898-6254 · pcoleary@buffalo.edu
Always discuss trial participation with your own doctor first.
| UCLA | Los Angeles, California, United States | Active Not Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Active Not Recruiting |
| University at Buffalo (the only clinical site where treatment is delivered) | Buffalo, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05127616